#MedicalResearch Archives

AASLD 2024丨Dr. Hui Wang’s Team: Serum HBV RNA and HBcrAg as Predictors of Low-Level Viremia in CHB Patients Treated with Nucleos(t)ide Analogs

By Mourabit Halima 2024.12.23

At the 2024 Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Dr. Hui Wang’s team from the Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao…

Call for Papers by November 24丨Beijing APASL 2025 Annual Meeting, Inviting Liver Disease Research Experts to Participate

By Peng Longmei 2024.11.04

The highly anticipated 34th Annual Meeting of the Asia-Pacific Association for the Study of the Liver (APASL 2025) will be held in Beijing from March 26 to 30, 2025. This…

Insights from Dr. Khalil Ghanem on the Challenges and Future of Syphilis Diagnosis, Treatment, and Prevention

By Ren Jiamo 2024.10.15

Editor's Note: As the incidence of syphilis continues to rise, clinicians are faced with an increasing number of patients with complex clinical presentations, posing significant challenges in patient management. At…

VITALITY Study Results Announced: Immunotherapy Shows Great Promise as a Neoadjuvant Treatment Before Liver Transplantation in Liver Cancer

By Lisa Cui 2024.09.19

Editor's Note: Immune checkpoint inhibitors (ICI) are gradually becoming a key therapeutic strategy in the neoadjuvant treatment of advanced hepatocellular carcinoma (HCC). Their widespread application reflects the deep understanding and…

The Lancet Gastroenterology & Hepatology: Dr. Qing Xie Leads Global Study on Infections in Hospitalized Cirrhosis Patients Across 24 Sub-centers!

By Peter W. PENG 2024.09.18

On September 4, Dr. Qing Xie's team from Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, published a research paper titled Global prevalence and characteristics of infections…

Delicate and Thin Fibrous Septa Indicate a Regression Tendency in MASH Patients with Advanced Fibrosis

By Mourabit Halima 2024.09.11

Editor’s Note: Metabolic dysfunction-associated steatohepatitis (MASH) represents a severe subtype of metabolic dysfunction-associated fatty liver disease (MAFLD), a global public health issue affecting over 25% of the global population. MASH…

Dr. Baiyi Chen: Key Elements in Early Empirical Treatment of Invasive Candidiasis

By Mourabit Halima 2024.08.28

Editor's Note: Candidiasis presents with a wide range of clinical manifestations, among which invasive candidiasis poses significant risks, leading to longer hospital stays, increased healthcare costs, and higher mortality rates.…

Dr. Jimmy Che-To LAI, two award winners, talks about the 2024 APASLAnnual Meeting

By Mourabit Halima 2024.04.29

From March 27 to 31, 2024, the 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2024) was held in Kyoto, Japan. As a top international conference, this year's APASL annual meeting brings together a large number of the latest research progress. After the feast, the heat did not abate. In the multi-day academic feast, what important research, cutting-edge views have been released, and what novel news events have occurred, let us listen to Dr. Jimmy Che-To LAI of the Chinese University of Hong Kong, China, and once again feel the pulse of Asia in the field of liver disease.

Advancements and Disparities in Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Multiple Myeloma: Insights from China

By Mourabit Halima 2024.03.20

Introduction: Autologous hematopoietic stem cell transplantation (AHSCT) has emerged as a pivotal therapeutic modality for lymphoma and multiple myeloma (MM), offering promising outcomes in improving patient prognosis. In China, the…

The Role of SHP-1 and SHP-2 in CD8+ T Cell Regulation during Lymphocytic Choriomeningitis Virus Infection: Insights into Stage-Specific Functional Interplay

By Mourabit Halima 2024.03.18

Abstract: Our study delves into the intricate interplay between Src homology region 2 domain-containing phosphatases 1 and 2 (SHP-1 and SHP-2) in orchestrating the functionality of CD8+ T cells during…